Publications and communications of Jean-Marie RAKIC

CHAPELLE, A.-C., RAKIC, J.-M., & Plant, G. (2022). 15th EUNOS Congress. Neuro-Ophthalmology, 46 (Suppl), 1-139. doi:10.1080/01658107.2022.2064188

Schoumacher, M., Lambert, V., Govaerts Bernadette, Rakic, J.-M., Noël, A., & De Tullio, P. (2022). From cohort study to the “real life” in patient’s follow-up and personalized medicine using NMR- based clinical metabolomics; results, issues, problems and prospects: the case of neovascular Age-related Macular Degeneration (nAMD) [Poster presentation]. Metabolomics 2022 Valence, valence, Spain.

GEORGES, A., Lavergne, A., Mandai, M., Lepiemme, F., Karim, L., Demeulenaere, L., Aguilar Ortmans, D., Schyns, M., Nguyen, L., RAKIC, J.-M., Takahashi, M., Georges, M., & Takeda, H. (2020). Combined analysis of single cell RNA-Seq and ATAC-Seq data reveals putative regulatory toggles operating in native and iPS-derived retina. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/292544. doi:10.1101/2020.03.02.972497

CHAPELLE, A.-C., & Rakic, J.-M. (2018). Les pathologies vasculaires oculaires : ouvrez l'oeil ! Revue Médicale de Liège, 73 (5-6), 351-358.

Mandal, J., Roth, M., Papakonstantinou, E., Sun, Q., Costa, L., Boeck, L., Scherr, A., Rakic, J.-M., Louis, R., Milenkovic, B., Boersma, W., Kostikas, K., Blasi, F., Aerts, J., Rohde, G., Lacoma, A., Torres, A., Welte, T., Tamm, M., & Stolz, D. (2018). Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD. Pulmonary Pharmacology and Therapeutics, 48, 111-116. doi:10.1016/j.pupt.2017.10.011

CHAPELLE, A.-C., BLAISE, P., & RAKIC, J.-M. (2016). La sclérite postérieure. Revue Médicale de Liège.

Brédart, S., Cornet, A., & RAKIC, J.-M. (30 May 2014). Recognition Memory for Colored and Blackand- White Scenes in Normal and Color Deficient Observers (Dichromats). PLoS ONE, 9 (5), 98757. doi:10.1371/journal.pone.0098757

Rémont, L., Duchesne, B., La, C., Rakic, J.-M., & Hick, S. (2014). Nouvelles approches des greffes de cornée. Revue Médicale de Liège, 69 (9), 490-6.

Detry, B., Blacher, S., Erpicum, C., Paupert, J., Maertens, L., Maillard, C., Munaut, C., Sounni, N. E., LAMBERT, V., Foidart, J.-M., Rakic, J.-M., Cataldo, D., & Noël, A. (2013). Sunitinib inhibits inflammatory corneal lymphangiogenesis. Investigative Ophthalmology and Visual Science, 54 (5), 3082-93. doi:10.1167/iovs.12-10856

Huvelle, H., Duchesne, B., & Rakic, J.-M. (2013). Comment je traite...un oeil rouge. Revue Médicale de Liège, 68 (12), 609-12.

Huvelle, H., Duchesne, B., & Rakic, J.-M. (2013). Comment j'explore ... le diagnostic différentiel d'un oeil rouge. Revue Médicale de Liège, 68 (11), 593-8.

LAMBERT, V., Lecomte, J., Hansen, S., Blacher, S., Alvarez Gonzalez, M.-L., Struman, I., Sounni, N. E., Rozet, E., De Tullio, P., Foidart, J.-M., Rakic, J.-M., & Noël, A. (2013). Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nature Protocols, 8 (11), 2197-2211. doi:10.1038/nprot.2013.135

SOHNGEN, P., BLAISE, P., Duchesne, B., & Rakic, J.-M. (2012). Panophtalmie post-traumatique fulgurante. Revue Médicale de Liège, 67 (9), 449-51.

Lecomte, J., Louis, K., Detry, B., Blacher, S., Lambert, V., Bekaert, S., Munaut, C., Paupert, J., Blaise, P., Foidart, J.-M., Rakic, J.-M., Krane, S. M., & Noël, A. (2011). Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization. Cellular and Molecular Life Sciences, 68, 677-686. doi:10.1007/s00018-010-0476-6

Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., LAMBERT, V., Alvarez Gonzalez, M.-L., Colige, A., Rakic, J.-M., Noël, A., Martial, J., & Struman, I. (2011). MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells. PLoS ONE, 6 (2), 16979. doi:10.1371/journal.pone.0016979

Bourguignont, A., Blaise, P., Janin, N., & Rakic, J.-M. (2010). Le cas clinique du mois. A propos d'un cas de maladie de von Hippel-Lindau. Revue Médicale de Liège, 65 (2), 62-6.

Dubail, J., Kesteloot, F., Deroanne, C., Motte, P., Lambert, V., Rakic, J.-M., Lapiere, C., Nusgens, B., & Colige, A. (2010). ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity. Cellular and Molecular Life Sciences. doi:10.1007/s00018-010-0431-6

Rakic, J.-M., COLLIGNON, N., Duchesne, B., & Van Cauwenberge, F. (2007). Resume d'une décennie de progrès ophtalmologiques. Revue Médicale de Liège, 62 (5-6), 467-70.

Jost, M., Maillard, C., Lambert, V., Tjwa, M., Blaise, P., Lecomte, J., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., & Noël, A. (2006). Plasminogen activator inhibitor type I (PAI-1) controls bone marrow-dependent and independent vascularization. Acta Clinica Belgica, 61 (2, MAR-APR), 87.

Xhauflaire, G., Uhoda, E., & Rakic, J.-M. (2005). Oeil et lumiere ultraviolette. Revue Médicale de Liège, 60 (Suppl 1), 99-102.

Blaise, P., Duchateau, E., Duchesne, B., Poutchinian, Y., & Rakic, J.-M. (December 2004). Les occlusions vasculaires retiniennes: diagnostic et prise en charge. Revue de Médecine Interne, 25 (12), 881-90. doi:10.1016/j.revmed.2004.03.010

Dubail, J., Kesteloot, F., Motte, P., Lambert, V., Rakic, J.-M., Lapière, C. M., Nusgens, B., & Colige, A. (2004). Effect of ADAMTS-2, a metalloproteinase containing a disintegrin domain and thrombospondin type I repeats, during angiogenesis in vitro and in vivo. Angiogenesis, 7 (2), 172.

Rakic, J.-M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J.-M., Munaut, C., & Noël, A. (July 2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Investigative Ophthalmology and Visual Science, 44 (7), 3186-3193. doi:10.1167/iovs.02-1092

Lambert, V., Munaut, C., Carmeliet, P., Gerard, R. D., Declerck, P. J., Gils, A., Claes, C., Foidart, J.-M., Rakic, J.-M., & Noël, A. (June 2003). Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type 1: Implications for clinical trials. Investigative Ophthalmology and Visual Science, 44 (6), 2791-2797. doi:10.1167/iovs.02-1179

Rakic, J.-M., Maillard, C., Jost, M., Bajou, K., Masson, V., Devy, L., Lambert, V., Foidart, J.-M., & Noël, A. (March 2003). Role of plasminogen activator-plasmin system in tumor angiogenesis. Cellular and Molecular Life Sciences, 60 (3), 463-473. doi:10.1007/s000180300039

Lambert, V., Wielockx, B., Munaut, C., Galopin, C., Jost, M., Itoh, T., Werb, Z., Baker, A., Krell, H. W., Foidart, J.-M., Rakic, J.-M., libert, C., & Noël, A. (2003). MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB Journal, 17 (15), 2290-2292. doi:10.1096/fj.03-0113fje

Rakic, J.-M., Lambert, V., Deprez, M., Foidart, J.-M., Noël, A., & Munaut, C. (2003). Estrogens reduce the expression of YKL-40 in the retina: Implications for eye and joint diseases. Investigative Ophthalmology and Visual Science, 44 (4), 1740-1746. doi:10.1167/iovs.02-0775

Lambert, V., Munaut, C., Jost, M., Werb, Z., Foidart, J.-M., Rakic, J.-M., & Noël, A. (October 2002). Matrix metalloproteinase-9 contributes to choroidal neovascularization. American Journal of Pathology, 161 (4), 1247-1253. doi:10.1016/S0002-9440(10)64401-X

Lambert, V., Munaut, C., Frankenne, F., Bajou, K., Gerard, R., Carmeliet, P., Defresne, M.-P., Foidart, J.-M., Rakic, J.-M., & Noël, A. (April 2001). Influence of Plasminogen Activator Inhibitor Type 1 on Choroidal Neovascularization. FASEB Journal, 15 (6), 1021-7. doi:10.1096/fj.00-0393com

Munaut, C., Lambert, V., Noël, A., Frankenne, F., Deprez, M., Foidart, J.-M., & Rakic, J.-M. (2001). Presence of Oestrogen Receptor Type Beta in Human Retina. British Journal of Ophthalmology, 85 (7), 877-82. doi:10.1136/bjo.85.7.877